SINOMAB BIO-B 03681Hong Kong Stock Exchange

1.1507.48%( +0.080 )
Closed: Oct 9 · Delayed · Hong Kong Stock Exchange
SINOMAB BIO-B (03681) Company Profile - Company Info, Industry & Management - cibo

Company Information

Market
HKEX Main Board
Listing Date
2019-11-12
Industry
Innovative Drugs & Biologics
Fiscal Year End
Dec 31
ISIN
HK0000544194

Industry

Innovative Drugs & Biologics 0.02%
124 stocks in this industry
Down 52 Up 57
Industry RankingsValue (HKD)Rank
Net Profit (Last FY)-123.11M67/125
ROE (Last FY)-20.67%81/117

Change is the 2026-10-09 close against the previous close; the industry change is the equal-weighted average of its stocks. Sub-industry classification is maintained by cibo. Last FY is each company's latest annual report. Net profit is profit attributable to owners of the parent; ROE = net profit / closing equity attributable to owners. Non-HKD statements are converted at ECB reference rates.

Management

NamePosition
Shui On LEUNG Executive Director
Xiaosu WANG Non-Executive Director
Lei XUE Non-Executive Director
Jianmin ZHANG Non-Executive Director
George William Hunter CAUTHERLEY Independent Non-Executive Director
Ping Cho Terence HON Independent Non-Executive Director
Chi Ming LEE Independent Non-Executive Director
Chi Sau Giselle LEE Independent Non-Executive Director
Nan SHEN Independent Non-Executive Director

Board list from the HKEXnews "List of Directors and their Role and Function", as of 2026-08-18.

About this page

This page shows SINOMAB BIO-B (03681) company information, related securities, the price change distribution and in-industry rankings within its sub-industry, and the board of directors. Quotes come from HKEX Daily Quotations, financial metrics from each company's latest annual report, and the director list from HKEXnews.